No association between the alpha-2 macroglobulin I1000V polymorphism and Alzheimer's disease

Neuroscience Letters

Volumn 262, Issue 2, 1999, Pages 137-139

  Wavrant Devrièze, Fabienne ^a   Rudrasingham, Varuni ^b   Lambert, Jean Charles ^c   Chakraverty, Sumi ^d   Kehoe, Patrick ^b   Crook, Richard ^a   Amouyel, Philippe ^c   Wu, William ^d   Holmans, Peter ^b,d   Rice, Francis ^d   Pérez Tur, Jordi ^a   Frigard, Bernard ^c   Morris, John C ^d   Carty, Stephanie ^b   Cottel, Dominique ^c   Tunstall, Nigel ^e   Lovestone, Simon ^e   Petersen, Ronald C ^f   Chartier Harlin, Marie Christine ^c   Goate, Alison ^d   Owen, Michael J ^b   Williams, Julie ^b   Hardy, John ^a   more..

^a MAYO CLINIC   (United States)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c INSTITUT PASTEUR DE LILLE   (France)

^d WASHINGTON UNIVERSITY   (United States)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f MAYO CLINIC ROCHESTER   (United States)

Author keywords

2 macroglobulin; Alzheimer's disease; Apolipoprotein E; Genetics

Indexed keywords

ALPHA 2 MACROGLOBULIN;

ADULT; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE LOCUS; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR; SIBLING;

AGE OF ONSET; ALLELES; ALPHA-MACROGLOBULINS; ALZHEIMER DISEASE; APOLIPOPROTEINS E; CASE-CONTROL STUDIES; GENE FREQUENCY; GENOTYPE; HUMANS; LINKAGE (GENETICS); LOD SCORE; MIDDLE AGED; NUCLEAR FAMILY; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 0033525766     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00035-X     Document Type: Article

References (15)

1. Blacker D., Haines J.L., Rodes L., Terwedow H., Go R.C., Harrell L.E., Perry R.T., Bassett S.S., Chase G., Meyers D., Albert M.S., Tanzi R. ApoE-4 and age at onset of Alzheimer's disease: the NIMH genetics initiative. Neurology. 48:1997;139-147.
2. Blacker D., Wilcox M.A., Laird N.M., Rodes L., Horvath S.M., Go R.C., Perry R., Watson B. Jr., Bassett S.S., McInnis M.G., Albert M.S., Hyman B.T., Tanzi R.E. Alpha-2 macroglobulin is genetically associated with Alzheimer disease. Nat. Genet. 19:1998;357-360.
3. Borth W. Alpha 2-macroglobulin, a multifunctional binding protein with targeting characteristics. FASEB J. 6:1992;3345-3353.
4. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., Pericak-Vance M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 261:1993;921-923.
5. Holmans P., Clayton D. Efficiency of typing unaffected relatives in an affected sib-pair linkage study with single-locus and multiple tightly linked markers. Am. J. Hum. Genet. 57:1995;1221-1232.
6. Holmans P. Asymptotic properties of affected sib-pair linkage analysis. Am. J. Hum. Genet. 52:1993;362-374.
7. Liao A., Nitsch R.M., Greenberg S.M., Finckh U., Blacker D., Albert M., Rebeck G.W., Gomez-Isla T., Clatworthy A., Binetti G., Hock C., Mueller-Thompson T., Mann U., Zuchowski K., Beisegel U., Staehlin H., Growdon J.H., Tanzi R.E., Hyman B.T. Genetic association of an α2-macroglobulin (Val100Ile) polymorphism and Alzheimer's disease. Hum. Mol. Genet. 7:1998;1953-1956.
8. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology. 34:1984;939-944.
9. Pericak-Vance M.A., Bass M.P., Yamaoka L.H., Gaskell P.C., Scott W.K., Terwedow H.A., Menold M.M., Conneally P.M., Small G.W., Vance J.M., Saunders A.M., Roses A.D., Haines J.L. Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12. J. Am. Med. Assoc. 278:1997;1237-1241.
10. Poller W., Faber J.-P., Klobeck G., Olek K. Cloning of the alpha 2-macroglogulin gene and detection of mutations in two functional domains: the bait region and the thiolester site. Human Genet. 88:1992;313-319.
11. Poller W., Faber J.-P., Olek K. Sequence polymorphism in the human alpha 2-macroglogulin (A2M) gene. Nucl. Acid Res. 19:1991;198.
12. Rogaeva E., Premkumar S., Song Y., Sorbi S., Brindle N., Paterson A., Duara R., Levesque G., Yu G., Nishimura M., Ikeda M., O'Toole C., Kawarai T., Jorge R., Vilarino D., Bruni A.C., Farrer L.A., St. George-Hyslop P.H. Evidence for an Alzheimer's disease susceptibility locus on chromosome 12 and for further locus heterogeneity. J. Am. Med. Assoc. 280:1998;614-618.
13. Strickland D.K., Ashcom J.D., Williams S., Burgess W.H., Migliorini M., Argraves W.S. Sequence identity between the alpha 2-macroglobulin receptor and low density lipoprotein receptor-related protein suggests that this molecule is a multifunctional receptor. J. Biol. Chem. 15(265):1990;17401-17404.
14. Van Leuven F., Stas L., Hilliker C., Lorent K., Umans L., Serneels L., Overbergh L., Torrekens S., Moechars D., De Stomner B., Van Den Berghe H. Structure of the gene (LRP1) coding for the human alpha 2-macroglobulin receptor lipoprotein receptor-related protein. Genomics. 24:1994;78-89.
15. Wu W.S., Holmans P., Wavrant-DeVrièze F., Shears S., Kehoe P., Crook R., Booth J., Williams N., Perez-Tur J., Roehl K., Fenton I., Chartier-Harlin M.C., Lovestone S., Williams J., Hutton M., Hardy J., Owen M.J., Goate A. Genetic studies on chromosome 12 in late-onset Alzheimer disease. J. Am. Med. Assoc. 280:1998;619-622.